ifosfamide has been researched along with Cancer of Intestines in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sangster, G | 1 |
| Kaye, SB | 1 |
| Calman, KC | 1 |
| Dalton, JF | 1 |
| Hoefer, H | 1 |
| Scheef, W | 1 |
| Titscher, R | 1 |
| Kokron, O | 1 |
1 trial available for ifosfamide and Cancer of Intestines
| Article | Year |
|---|---|
[Treatment of bronchogenic cancer and lung metastases of solid tumors with ifosfamid (author's transl)].
Topics: Carcinoma, Bronchogenic; Clinical Trials as Topic; Cyclophosphamide; Drug Evaluation; Female; Humans | 1974 |
1 other study available for ifosfamide and Cancer of Intestines
| Article | Year |
|---|---|
Failure of 2-mercaptoethane sulphonate sodium (mesna) to protect against ifosfamide nephrotoxicity.
Topics: Adult; Cyclophosphamide; Fanconi Syndrome; Female; Humans; Ifosfamide; Intestinal Neoplasms; Leiomyo | 1984 |